Adaptin Bio (APTN) Accumulated Expenses (2024 - 2026)
Adaptin Bio (APTN) posted Accumulated Expenses of $869681.0 for Q1 2026, up 45.81% sequentially from $596465.0 in Q4 2025, and up 11.26% YoY from $781683.0 in Q1 2025.
Adaptin Bio (APTN) Accumulated Expenses (2024 - 2026) Analysis & Trends
Adaptin Bio has reported Accumulated Expenses for 3 years, with the latest figure at $869681.0 in Q1 2026.
- Quarterly Accumulated Expenses rose 11.26% year-over-year to $869681.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $869681.0 (up 11.26% YoY) and the FY2025 annual result came in at $596465.0, up 342.24% from the prior year.
- Accumulated Expenses advanced to $869681.0 in Q1 2026 per APTN's latest filing, from $596465.0 in the prior quarter.
- Over five years, Accumulated Expenses peaked at $869681.0 in Q1 2026 and troughed at $134875.0 in Q4 2024.
- A 3-year average of $571139.3 and a median of $559470.5 in 2025 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2025 and 2026: Accumulated Expenses surged 342.24% in 2025, then climbed 11.26% in 2026.
- Over 3 years, Accumulated Expenses stood at $134875.0 in 2024, then jumped by 342.24% to $596465.0 in 2025, then surged by 45.81% to $869681.0 in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $869681.0, $596465.0, and $522476.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 810,589.00 |
| Mar 31, 2026 | 869,681.00 |
| Dec 31, 2025 | 596,465.00 |
| Sep 30, 2025 | 522,476.00 |
| Jun 30, 2025 | 521,656.00 |
| Mar 31, 2025 | 781,683.00 |
| Dec 31, 2024 | 134,875.00 |